Retinal vascular disorders. Disorders of choroid and retina
Conditions
Interventions
one intravitreal injection 0.05 ml of ziv-ablicerpt in one eye of each patient with retinal disease(AMD, CRVO) and monitor vision and OCT 1 day and 1 week after injection.
Treatment - Drugs
one intravitreal injection 0.05 ml of ziv-ablicerpt in one eye of each patient with retinal disease(AMD, CRVO) and monitor vision and OCT 1 day and 1 week after injection
Sponsors
Investigator
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria :Eyes with active neovascularage-related macular degeneration (AMD) or diabetic macular edema (DME), best-corrected visual acuity of 20/100 (6/30) or less, the ability to comprehend the risks and benefits of the study, and the ability to sign the consent form; Exclusion criteria : Signs of ocular infection and a history of myocardial infarction or cerebrovascular accident.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Best corrected visual acuities. Timepoint: In the beginning of the study, and 1 day and 1 week after Zal-trap injection. Method of measurement: By the same examiner, using Snellen charts. | — |
Secondary
| Measure | Time frame |
|---|---|
| The height of retinal pigment epithelium detachment. Timepoint: In the beginning of the study and 1 day and 1 week after Zal-trap injection. Method of measurement: On the horizontal scan and vertical scan passing through the foveola through averaging the horizontal and vertical measures. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kamran Jalali
Noor Eye Hospital
Outcome results
None listed